Current status of clostridium difficile infection epidemiology

Clinical Infectious Diseases

Volumn 55, Issue SUPPL.2, 2012, Pages

  Lessa, Fernanda C ^a   Gould, Carolyn V ^a   Clifford McDonald, L ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; FECES CULTURE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MOLECULAR EPIDEMIOLOGY; MORTALITY; PATHOGENESIS; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; UNITED STATES;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; GENES, BACTERIAL; GENETIC VARIATION; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; PUBLIC HEALTH; RISK FACTORS; UNITED STATES;

EID: 84863676446     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis319     Document Type: Review

References (46)

1. Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficile. Am J Dis Child 1935; 49:390-402.
2. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxinproducing clostridia. N Engl J Med 1978; 298:531-4. (Pubitemid 8295586)
3. Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974; 81:429-33.
4. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41. (Pubitemid 41770164)
5. Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a realtime PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009; 47:3211-7.
6. Tenover FC, Novak-Weekley S, Woods CW, et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 2010; 48:3719-24.
7. Shaughnessy MK, Micielli RL, Depestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32:201-6.
8. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-10. (Pubitemid 19034145)
9. Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12(Suppl 6): 2-18. (Pubitemid 44362038)
10. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359:1932-40.
11. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26:1027-34.
12. Gould CV, McDonald LC. Bench-to-bedside review: Clostridium difficile colitis. Crit Care 2008; 12:203.
13. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. Infect Dis 1992; 166:561-7.
14. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among longterm care facility residents. Clin Infect Dis 2007; 45:992-8. (Pubitemid 47580347)
15. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhea. Lancet 1998; 351:633-6. (Pubitemid 28098446)
16. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409-15.
17. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13:1417-9. (Pubitemid 47510317)
18. Burckhardt F, Friedrich A, Beier D, Eckmanns T. Clostridiumdifficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008; 14:691-2. (Pubitemid 351520889)
19. Gravel D, Miller M, Simor A, et al. Canadian Nosocomial Infection Surveillance Program. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program study. Clin Infect Dis 2009; 48:568-76.
20. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillinresistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011; 32:387-90.
21. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays. Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. Statistical brief #124. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf. Accessed 3 April 2012.
22. Agency for Healthcare Research and Quality. National and regional estimates on hospital use for all patients from the HCUP Nationwide Inpatient Sample (NIS). Available at: http://www.hcup-us.ahrq.gov/db/nation/nis/ nissummstats.jsp. Accessed 3 April 2012.
23. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009; 30:526-33.
24. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A casecontrol study of community-associated Clostridium difficile infection. Antimicrob Chemother 2008; 62:388-96. (Pubitemid 351984787)
25. Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010; 16:197-204.
26. Lambert PJ, Dyck M, Thompson LH, Hammond GW. Populationbased surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol 2009; 30:945-51.
27. Miniño AM, Xu JQ, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010; 59. Hyattsville, MD: National Center for Health Statistics. http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59-02.pdf. Accessed 10 September 2011.
28. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16:604-9.
29. Al-Jumaili IJ, ShibleyM, Lishman AH, Record CO. Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol 1984; 19:77-8. (Pubitemid 14213309)
30. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011; 30:580-4.
31. Tai E, Richardson LC, Townsend J, Howard E, McDonald LC. Clostridium difficile infection among children with cancer. Pediatr Infect Dis J 2011; 30:610-2.
32. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201-5.
33. Kuntz JL, Yang M, Cavanaugh J, Saftlas AF, Polgreen PM. Trends in Clostridium difficile infection among peripartum women. Infect Control Hosp Epidemiol 2010; 31:532-4.
34. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079-84. (Pubitemid 41338761)
35. Stabler RA, Dawson LF, Phua LT, Wren BW. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J Med Microbiol 2008; 57:771-5. (Pubitemid 351842071)
36. Stabler RA, He M, Dawson L, et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 2009; 10:R102.
37. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 2009; 14:pii 19402.
38. Bauer MP, Notermans DW, van Benthem BH, et al. ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377:63-73.
39. Belmares J, Johnson S, Parada JP, et al. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. Clin Infect Dis 2009; 49:1141-7.
40. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann InternMed 1994; 120:272-7. (Pubitemid 24050022)
41. Belmares J, Pua H, Schreckenberger P, Parada J. The paradox of accuracy-C. difficile (CD) polymerase chain reaction (PCR) increases nosocomial CD rates while decreasing CD-related isolation days [abstract 150]. Presented at: SHEA 2011 Annual Scientific Meeting, 1-4 April 2011; Dallas, Texas.
42. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-5. (Pubitemid 46374153)
43. The National Healthcare Safety Network Manual. Patient Safety Component. Protocol Multidrug-Resistant Organism (MDRO) and Clostridium difficile-Associated Disease (CDAD) Module. Available at: http://www.cdc.gov/ nhsn/PDFs/MDRO-CDADprotocolv41Dec08final.pdf. Accessed 10 September 2011.
44. The National Healthcare Safety Network Clinical Document Architecture (CDA). Available at: http://www.cdc.gov/nhsn/CDA-eSurveillance.html. Accessed 3 April 2012.
45. Benoit SR, McDonald LC, English R, Tokars JI. Automated surveillance of Clostridium difficile infections using BioSense. Infect Control Hosp Epidemiol 2011; 32:26-33.
46. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs). Available at: http://www.cdc.gov/HAI/surveillance/monitorHAI. html. Accessed 10 September 2011.